CLOSEOUT LETTER
Soapwalla Inc. MARCS-CMS 519062 —
- Recipient:
- Soapwalla Inc.
United States
- Issuing Office:
United States
|
|
Office of Human and Animal Food Operations East |
|
|
VIA UNITED PARCEL SERVICE
DELIVERY SIGNATURE REQUEST
September 28, 2017
Ms. Rachel Winard, Founder
Soapwalla, Inc.
232 Third Street, Suite B303
Brooklyn, NY 11215
Dear Ms. Winard:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter CMS# 519062, issued on June 15, 2017. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
CDR Catherine Beer
Acting Director, Compliance Branch
Office of Human and Animal Food Operations East Division 1